Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sen-Lin Ji

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Yi Chuan = Hereditas|July 28, 2006
[PPARgamma variants and complex diseases]Sen-Lin Ji, Qing-Yang Huang
Yi Chuan Xue Bao = Acta Genetica Sinica|August 1, 2006
Linkage and association studies of the susceptibility genes for type 2 diabetesQing-Yang Huang, Meng-Rong Cheng, Sen-Lin Ji
International Journal of Medicinal Mushrooms|June 18, 2015
Enhanced Production of Polysaccharide Through the Overexpression of Homologous Uridine Diphosphate Glucose Pyrophosphorylase Gene in a Submerged Culture of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes)Sen-Lin Ji, Rui Liu, Meng-Fei Ren, et al.
International Journal of Medicinal Mushrooms|June 19, 2014
Development of an expression plasmid and its use in genetic manipulation of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (higher Basidiomycetes)Xuya Yu, Sen-Lin Ji, Yi-Long He, et al.
International Immunopharmacology|April 20, 2025
Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseasesHuaiping Tang, Xinxin Zou, Peipei Chen, et al.
International Immunopharmacology|November 23, 2025
Corrigendum to "Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases" [Int. Immunopharmacol. 156 (2025) 114687]Huaiping Tang, Xinxin Zou, Peipei Chen, et al.
Cellular Immunology|November 1, 2024
Gastrodenol suppresses NLRP3/GSDMD mediated pyroptosis and ameliorates inflammatory diseasesPeipei Chen, Yunshu Wang, Huaiping Tang, et al.
Journal of Pharmaceutical Analysis|February 4, 2025
New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3Peipei Chen, Yunshu Wang, Huaiping Tang, et al.
Bioprocess and Biosystems Engineering|September 15, 2014
Increased polysaccharide production and biosynthetic gene expressions in a submerged culture of Ganoderma lucidum by the overexpression of the homologous α-phosphoglucomutase geneJun-Wei Xu, Sen-Lin Ji, Huan-Jun Li, et al.
Medcomm|April 27, 2026
High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome InhibitorSen-Lin Ji, Peipei Chen, Huaiping Tang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Yi Chuan = Hereditas|July 28, 2006
[PPARgamma variants and complex diseases]Sen-Lin Ji, Qing-Yang Huang
Yi Chuan Xue Bao = Acta Genetica Sinica|August 1, 2006
Linkage and association studies of the susceptibility genes for type 2 diabetesQing-Yang Huang, Meng-Rong Cheng, Sen-Lin Ji
International Journal of Medicinal Mushrooms|June 18, 2015
Enhanced Production of Polysaccharide Through the Overexpression of Homologous Uridine Diphosphate Glucose Pyrophosphorylase Gene in a Submerged Culture of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes)Sen-Lin Ji, Rui Liu, Meng-Fei Ren, et al.
International Journal of Medicinal Mushrooms|June 19, 2014
Development of an expression plasmid and its use in genetic manipulation of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (higher Basidiomycetes)Xuya Yu, Sen-Lin Ji, Yi-Long He, et al.
International Immunopharmacology|April 20, 2025
Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseasesHuaiping Tang, Xinxin Zou, Peipei Chen, et al.
International Immunopharmacology|November 23, 2025
Corrigendum to "Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases" [Int. Immunopharmacol. 156 (2025) 114687]Huaiping Tang, Xinxin Zou, Peipei Chen, et al.
Cellular Immunology|November 1, 2024
Gastrodenol suppresses NLRP3/GSDMD mediated pyroptosis and ameliorates inflammatory diseasesPeipei Chen, Yunshu Wang, Huaiping Tang, et al.
Journal of Pharmaceutical Analysis|February 4, 2025
New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3Peipei Chen, Yunshu Wang, Huaiping Tang, et al.
Bioprocess and Biosystems Engineering|September 15, 2014
Increased polysaccharide production and biosynthetic gene expressions in a submerged culture of Ganoderma lucidum by the overexpression of the homologous α-phosphoglucomutase geneJun-Wei Xu, Sen-Lin Ji, Huan-Jun Li, et al.
Medcomm|April 27, 2026
High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome InhibitorSen-Lin Ji, Peipei Chen, Huaiping Tang, et al.
Pageof 2